var data={"title":"Epidemiology and etiology of osteoporosis in men","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology and etiology of osteoporosis in men</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/contributors\" class=\"contributor contributor_credentials\">Joel S Finkelstein, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/contributors\" class=\"contributor contributor_credentials\">Elaine W Yu, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/contributors\" class=\"contributor contributor_credentials\">Clifford J Rosen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/contributors\" class=\"contributor contributor_credentials\">Jean E Mulder, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 01, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Osteoporosis is a leading cause of morbidity and mortality in older people. While less common in men than women, approximately 1.5 million men over age 65 years in the United States have osteoporosis, and another 3.5 million men are at risk [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The disorders that cause osteoporosis in men are similar to those in women (<a href=\"image.htm?imageKey=ENDO%2F60440\" class=\"graphic graphic_table graphicRef60440 \">table 1</a>). Epidemiological surveys suggest that causes or contributing factors for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/2-4\" class=\"abstract_t\">2-4</a>]. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anticonvulsant drug therapy, hypercalciuria, and alcohol abuse were among the most common identifiable causes of osteoporosis in these surveys [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/3-6\" class=\"abstract_t\">3-6</a>].</p><p>The epidemiology and etiology of osteoporosis in men will be reviewed here. Fracture risk assessment and the evaluation and treatment of osteoporosis in men are discussed separately. (See <a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment\" class=\"medical medical_review\">&quot;Osteoporotic fracture risk assessment&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-men\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and evaluation of osteoporosis in men&quot;</a> and <a href=\"topic.htm?path=treatment-of-osteoporosis-in-men\" class=\"medical medical_review\">&quot;Treatment of osteoporosis in men&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In men, as in women, the incidence of hip fractures increases exponentially with age, although the increase begins approximately 10 years later (<a href=\"image.htm?imageKey=ENDO%2F58577\" class=\"graphic graphic_figure graphicRef58577 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The following observations illustrate the magnitude of the problem in men:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Worldwide, 39 percent of annual osteoporotic fractures occur in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A 60-year-old man has an approximately 25 percent chance of having an osteoporotic fracture during his lifetime [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/9\" class=\"abstract_t\">9</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>By the age of 90 years, one of every six men will have a hip fracture. The prevalence of vertebral or hip fracture in older men is approximately one-third that in women (5 to 6 percent versus 16 to 18 percent), and Colles' fracture one-sixth as common (2.5 versus 16 percent) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/10\" class=\"abstract_t\">10</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The mortality rate associated with hip fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/11-14\" class=\"abstract_t\">11-14</a>], as well as vertebral and other major fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/15\" class=\"abstract_t\">15</a>], is higher in men than in women. In addition, men are even less likely than women to be evaluated or receive antiresorptive therapy after a hip fracture (4.5 versus 49.5 percent, respectively) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/12,16\" class=\"abstract_t\">12,16</a>]. (See <a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women#H6682091\" class=\"medical medical_review\">&quot;Overview of the management of osteoporosis in postmenopausal women&quot;, section on 'Postfracture'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Decreased bone mass can occur because peak bone mass is low, bone resorption is excessive after peak bone mass is obtained, or bone formation during remodeling is decreased. All three processes are likely to contribute, in varying degrees, to osteoporosis in individual patients. (See <a href=\"topic.htm?path=pathogenesis-of-osteoporosis\" class=\"medical medical_review\">&quot;Pathogenesis of osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Peak bone mass</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In men, bone mineral density (BMD) increases markedly during puberty in response to increasing sex steroid production [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Much of this apparent increase, particularly for cortical bone, is due to an increase in bone size. Peak spinal bone density is reached at approximately 20 years [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/19-21\" class=\"abstract_t\">19-21</a>], while the peak density of the radius and femoral shaft is reached somewhat later [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/20-22\" class=\"abstract_t\">20-22</a>].</p><p>The importance of normal sex steroid production in the acquisition of peak bone mass is illustrated by the findings of low bone mass in young men with idiopathic hypogonadotropic hypogonadism (IHH) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/23,24\" class=\"abstract_t\">23,24</a>]. Because IHH is almost always a congenital abnormality due to gonadotropin-releasing hormone (GnRH) deficiency, this disorder provides a valuable model to assess the effects of hypogonadism on pubertal bone development (ie, the attainment of peak bone mass). Both cortical (<a href=\"image.htm?imageKey=ENDO%2F69980\" class=\"graphic graphic_figure graphicRef69980 \">figure 2</a>) and trabecular bone density (<a href=\"image.htm?imageKey=ENDO%2F71184\" class=\"graphic graphic_figure graphicRef71184 \">figure 3</a>) are markedly decreased in these men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/23,24\" class=\"abstract_t\">23,24</a>]. Osteoporosis can be detected even before the attainment of skeletal maturity, suggesting that it is due to inadequate pubertal bone accretion rather than postmaturity bone loss. The clinical manifestations and genetics of IHH are reviewed in detail separately. (See <a href=\"topic.htm?path=isolated-gonadotropin-releasing-hormone-deficiency-idiopathic-hypogonadotropic-hypogonadism\" class=\"medical medical_review\">&quot;Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)&quot;</a>.)</p><p>Although the observation that peak BMD is reduced in men with congenital hypogonadism illustrates the importance of gonadal steroids in bone development, those findings do not indicate whether androgens, estrogens, or both are primarily responsible for the pubertal increase in BMD and the attainment of peak bone mass. Reports that BMD is markedly reduced in men with null mutations in the estrogen receptor-alpha, so that responsiveness to estrogen is essentially absent, or in men with null mutation in the aromatase gene, so that synthesis of estradiol is virtually absent, strongly suggest that estrogens provide the primary hormonal stimulus to the attainment of peak bone mass. (See <a href=\"#H6\" class=\"local\">'The role of hormones'</a> below.)</p><p>Another important determinant of peak bone density is the timing of puberty. In adult men with history of constitutionally delayed puberty, BMD of the radial shaft, lumbar spine (LS), and proximal femur is significantly lower than in age-matched normal men, and it does not appear to improve with time [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/25,26\" class=\"abstract_t\">25,26</a>]. Similar findings have been reported in adolescent boys with delayed puberty [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/27\" class=\"abstract_t\">27</a>]. These observations suggest that there is a critical time period during which the skeleton is responsive to sex steroids. (See <a href=\"topic.htm?path=diagnosis-and-treatment-of-delayed-puberty\" class=\"medical medical_review\">&quot;Diagnosis and treatment of delayed puberty&quot;</a>.)</p><p>Other factors that determine peak bone mass are genetic predisposition, chronic illnesses, and medications that negatively impact bone density accrual. (See <a href=\"topic.htm?path=pathogenesis-of-osteoporosis#H341616\" class=\"medical medical_review\">&quot;Pathogenesis of osteoporosis&quot;, section on 'Peak bone mass acquisition'</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Age-related bone loss</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>After attainment of peak bone mass, men lose approximately 30 percent of their trabecular bone and 20 percent of their cortical bone during their lifetimes. Trabecular bone loss appears to start in young adult life, whereas cortical bone loss is either less pronounced or begins later in life [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/28\" class=\"abstract_t\">28</a>]. In some studies, the decline in femoral neck density began shortly after attainment of peak bone mass [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/29,30\" class=\"abstract_t\">29,30</a>], and the rate of femoral neck bone loss increased with aging [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/30,31\" class=\"abstract_t\">30,31</a>]. One study reported that bone mineral content of the proximal and distal radius declined at a rate of approximately 1 percent per year after the age of 30 years, whereas another study found that cortical BMD remained stable until later in life [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/28,32\" class=\"abstract_t\">28,32</a>].</p><p>Patterns of change in spine BMD vary depending upon the measurement technique. When measured by quantitative computed tomography (QCT), which assesses only vertebral body trabecular BMD, spine BMD declines more rapidly than hip or radius BMD [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/32,33\" class=\"abstract_t\">32,33</a>]. When spine BMD is measured by dual-energy x-ray absorptiometry (DXA) in the posterior-anterior projection, it often appears to increase in older men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/31,34,35\" class=\"abstract_t\">31,34,35</a>], likely due to degenerative changes in the posterior spinous elements (<a href=\"image.htm?imageKey=ENDO%2F53843\" class=\"graphic graphic_figure graphicRef53843 \">figure 4</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/34\" class=\"abstract_t\">34</a>]. Thus, posterior-anterior DXA should be interpreted cautiously when assessing bone density of the spine in older men. (See <a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry#H5\" class=\"medical medical_review\">&quot;Overview of dual-energy x-ray absorptiometry&quot;, section on 'Clinical applications of DXA'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">The role of hormones</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although gonadal steroids appear to play a crucial role in the attainment of peak bone mass, whether they play a significant role in age-related bone loss is less clear. Unlike in women, the rate of age-related gonadal steroid decline is less abrupt in men, and thus, the skeletal impact of these more subtle declines are unclear. However, gonadal levels at the extremes of deficiency have been associated with low BMD and bone loss in older men. Numerous epidemiologic studies have reported associations between gonadal steroids and BMD or fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/36-40\" class=\"abstract_t\">36-40</a>]. These associations are weak, however, as might be expected when studying different populations and relating a single hormone measurement to complex endpoints like bone density and fracture.</p><p class=\"headingAnchor\" id=\"H2236970300\"><span class=\"h3\">Testosterone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some studies have reported significant associations between testosterone, free testosterone, <span class=\"nowrap\">and/or</span> bioavailable testosterone and BMD, rates of bone loss, and prevalent fragility fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/36-38\" class=\"abstract_t\">36-38</a>]. As an example, in the Osteoporotic Fractures in Men Study (MrOS), a cross-sectional and longitudinal study of 2447 men over age 65 years, the prevalence of osteoporosis in the hip or rapid hip bone loss was threefold higher in men whose total testosterone levels were &lt;200 <span class=\"nowrap\">ng/dL</span> (6.9 <span class=\"nowrap\">nmol/L)</span> compared with &gt;200 <span class=\"nowrap\">ng/dL</span> (<a href=\"image.htm?imageKey=ENDO%2F68642\" class=\"graphic graphic_figure graphicRef68642 \">figure 5</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Estrogen</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, associations of bone density with estrogens have been slightly stronger than associations with androgens [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/39\" class=\"abstract_t\">39</a>]. In the MrOS study, the prevalence of osteoporosis in the hip (T-score &lt;-2.5) increased progressively as total or bioavailable estradiol levels fell (<a href=\"image.htm?imageKey=ENDO%2F68642\" class=\"graphic graphic_figure graphicRef68642 \">figure 5</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/36\" class=\"abstract_t\">36</a>]. In addition, low serum estradiol levels have been associated with an increased risk of future hip fracture in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/40\" class=\"abstract_t\">40</a>]. Fracture risk appears to be even greater in men with low serum estradiol and testosterone concentrations [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/39,40\" class=\"abstract_t\">39,40</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Estrogen versus testosterone</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several studies have evaluated the relative contributions of sex steroids in the regulation of bone resorption and formation (as measured by urinary and serum markers and BMD) in adult men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/41-43\" class=\"abstract_t\">41-43</a>]. Estrogen appears to have the dominant effect on bone resorption and formation.</p><p>In one physiologic study of induced hypogonadism, 198 healthy men (ages 20 to 50 years) were treated with a GnRH agonist (to temporarily suppress endogenous sex steroid production) and were then randomized to receive 0 (placebo), 1.25, 2.5, 5, or 10 grams of a testosterone gel daily for 16 weeks [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/43\" class=\"abstract_t\">43</a>]. A second group of 202 healthy men received the same agents plus <a href=\"topic.htm?path=anastrozole-drug-information\" class=\"drug drug_general\">anastrozole</a> (to suppress aromatization of testosterone to estradiol).</p><p>By comparing changes in bone turnover markers, BMD by DXA, and BMD by QCT between men who did and did not receive <a href=\"topic.htm?path=anastrozole-drug-information\" class=\"drug drug_general\">anastrozole</a>, the study demonstrated that increases in bone resorption and decreases in BMD in hypogonadal men were largely due to estrogen deficiency. The risk of developing hypogonadal bone loss appeared to be small until serum estradiol levels fell below 10 <span class=\"nowrap\">pg/mL</span> <span class=\"nowrap\">and/or</span> serum testosterone levels fell below 200 <span class=\"nowrap\">ng/dL</span>.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Complete androgen insensitivity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subjects with complete androgen insensitivity provide a valuable model to assess whether the sexual dimorphism in peak bone density is genetically or hormonally determined. In these subjects, who are genetic males but phenotypic females, radial shaft density is lower than that of normal men but similar to that of normal women. In contrast, LS density is lower than expected for either men or women of the same age [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/44-46\" class=\"abstract_t\">44-46</a>]. These findings suggest that androgen action contributes to the normal sexual dimorphism in cortical bone density and that the Y chromosome, per se, is not sufficient to guarantee the higher cortical density of normal men. Insufficient replacement of estradiol after gonadectomy, however, cannot be excluded as a reason for these results. As an example, in one study, noncompliance with estrogen replacement therapy after gonadectomy correlated with lower LS bone density [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=pathogenesis-and-clinical-manifestations-of-disorders-of-androgen-action#H3\" class=\"medical medical_review\">&quot;Pathogenesis and clinical manifestations of disorders of androgen action&quot;, section on 'Complete androgen insensitivity (CAIS)'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Other hormones</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other hormonal changes that may be associated with age-related bone loss include higher serum parathyroid hormone (PTH) concentrations and lower serum 25-hydroxyvitamin D and insulin-like growth factor-1 (IGF-1) concentrations [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/47-49\" class=\"abstract_t\">47-49</a>]. Suppression of gonadal steroids in older men with a GnRH agonist increases the skeletal responsiveness to pharmacologic doses of exogenous PTH, an observation that might help to explain bone loss in men with hypogonadism [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/50\" class=\"abstract_t\">50</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">RISK FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to low peak bone mass and age-related bone loss, a number of factors contribute to the development of osteoporosis and fracture in men. In a meta-analysis of 55 observational studies, low body mass index (BMI), excessive alcohol intake (daily intake or &gt;10 servings per week), current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes were significantly associated with low bone density-related fractures in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/51\" class=\"abstract_t\">51</a>].</p><p>Several endocrine, gastrointestinal, and hematologic disorders are also associated with osteoporosis. The medical disorders that cause osteoporosis in men are similar to those in women (<a href=\"image.htm?imageKey=ENDO%2F60440\" class=\"graphic graphic_table graphicRef60440 \">table 1</a>). Epidemiological surveys suggest that causes for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/2-4\" class=\"abstract_t\">2-4</a>]. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anticonvulsant drug therapy, hypercalciuria, and alcohol abuse were among the most common identifiable causes of osteoporosis in these surveys [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/3-6\" class=\"abstract_t\">3-6</a>].</p><p>Brief comments on some of these risk factors follow; more detailed reviews are presented elsewhere. (See <a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">&quot;Clinical features and evaluation of glucocorticoid-induced osteoporosis&quot;</a> and <a href=\"topic.htm?path=bone-disease-with-hyperthyroidism-and-thyroid-hormone-therapy\" class=\"medical medical_review\">&quot;Bone disease with hyperthyroidism and thyroid hormone therapy&quot;</a> and <a href=\"topic.htm?path=bone-disease-in-diabetes-mellitus\" class=\"medical medical_review\">&quot;Bone disease in diabetes mellitus&quot;</a> and <a href=\"topic.htm?path=metabolic-bone-disease-in-inflammatory-bowel-disease\" class=\"medical medical_review\">&quot;Metabolic bone disease in inflammatory bowel disease&quot;</a> and <a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">&quot;Drugs that affect bone metabolism&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1525134674\"><span class=\"h2\">Hypogonadism</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypogonadism is the best-characterized risk factor for osteoporosis in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/3,4,52-54\" class=\"abstract_t\">3,4,52-54</a>]. Cross-sectional studies demonstrate that bone mineral density (BMD) is reduced in men with primary or secondary hypogonadism (<a href=\"image.htm?imageKey=ENDO%2F64482\" class=\"graphic graphic_figure graphicRef64482 \">figure 6</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/23,55-59\" class=\"abstract_t\">23,55-59</a>], men with constitutional delay of puberty [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/25,26\" class=\"abstract_t\">25,26</a>], idiopathic hypogonadotropic hypogonadism (IHH) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/23,24\" class=\"abstract_t\">23,24</a>], and subjects with androgen insensitivity [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/44,45\" class=\"abstract_t\">44,45</a>]. (See <a href=\"topic.htm?path=causes-of-primary-hypogonadism-in-males\" class=\"medical medical_review\">&quot;Causes of primary hypogonadism in males&quot;</a> and <a href=\"topic.htm?path=causes-of-secondary-hypogonadism-in-males\" class=\"medical medical_review\">&quot;Causes of secondary hypogonadism in males&quot;</a> and <a href=\"topic.htm?path=diagnosis-and-treatment-of-disorders-of-the-androgen-receptor\" class=\"medical medical_review\">&quot;Diagnosis and treatment of disorders of the androgen receptor&quot;</a>.)</p><p>Bone turnover increases and bone density decreases in men with serum testosterone levels that are below approximately 200 <span class=\"nowrap\">ng/dL,</span> likely due to a concomitant decline in serum estradiol levels to below 10 to 15 <span class=\"nowrap\">pg/mL</span> [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/43\" class=\"abstract_t\">43</a>]. The low bone density does not appear to be due to dihydrotestosterone deficiency, as men treated with <a href=\"topic.htm?path=finasteride-drug-information\" class=\"drug drug_general\">finasteride</a>, which inhibits conversion of testosterone to dihydrotestosterone, do not have accelerated bone loss [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/60\" class=\"abstract_t\">60</a>].</p><p>Osteoporosis has also been reported in hypogonadal men with hemochromatosis [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/56,61\" class=\"abstract_t\">56,61</a>] and anorexia nervosa [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/62\" class=\"abstract_t\">62</a>]. In these men, it is difficult to determine whether the osteopenia is due to concomitant liver disease and nutritional deficiencies or to hypogonadism. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemochromatosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of hereditary hemochromatosis&quot;</a>.)</p><p>There have been few longitudinal studies of men at risk for osteoporosis as a result of hypogonadism. Bone density decreases in young men who are castrated for sexual delinquency [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/63\" class=\"abstract_t\">63</a>] and in older men with advanced prostate cancer who undergo androgen ablation therapy [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/64-67\" class=\"abstract_t\">64-67</a>]. (See <a href=\"topic.htm?path=side-effects-of-androgen-deprivation-therapy#H7\" class=\"medical medical_review\">&quot;Side effects of androgen deprivation therapy&quot;, section on 'Osteoporosis and bone fractures'</a>.)</p><p>Severe hypogonadism increases the risk of fractures in men:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one study of 235 men with prostate cancer, 14 percent of those treated with orchiectomy (n = 59) later had osteoporotic fractures, compared with 1 percent in those who did not undergo orchiectomy (n = 176) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/68\" class=\"abstract_t\">68</a>]. Among the 16 men who survived for at least five years after orchiectomy, six (38 percent) had a nontraumatic fracture that was not attributable to their cancer.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The increase in fracture risk with androgen deprivation therapy (rather than orchiectomy) may be more modest. This was illustrated in a much larger study of 50,613 men with a diagnosis of prostate cancer; 19 percent of 6650 men who survived at least five years after diagnosis (and who received androgen-deprivation therapy) had a fracture (compared with 12 percent of the 20,035 patients who did not receive androgen-deprivation therapy) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/69\" class=\"abstract_t\">69</a>].</p><p/><p>Reduction in BMD can be detected after as little as six to nine months of androgen deprivation therapy. Thus, all men beginning such therapy should receive calcium and vitamin D and maintain a moderate exercise regimen [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/70\" class=\"abstract_t\">70</a>]. Treatment with calcium and vitamin D alone, however, is not sufficient to prevent bone loss in these men. Baseline measurement of bone density and periodic reassessment during therapy are appropriate, and bisphosphonate therapy should be considered. (See <a href=\"topic.htm?path=treatment-of-osteoporosis-in-men\" class=\"medical medical_review\">&quot;Treatment of osteoporosis in men&quot;</a> and <a href=\"topic.htm?path=side-effects-of-androgen-deprivation-therapy#H7\" class=\"medical medical_review\">&quot;Side effects of androgen deprivation therapy&quot;, section on 'Osteoporosis and bone fractures'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Lifestyle factors</span></p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h3\">Smoking and alcohol</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both cigarette smoking and excess alcohol intake are associated with increased rates of bone loss and fracture [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/51,71\" class=\"abstract_t\">51,71</a>] (see <a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment#H23\" class=\"medical medical_review\">&quot;Osteoporotic fracture risk assessment&quot;, section on 'Cigarette smoking'</a>). Alcohol intake is inversely associated with bone density in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/72,73\" class=\"abstract_t\">72,73</a>], and osteoporotic fractures are common in alcoholic men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/4,74\" class=\"abstract_t\">4,74</a>]. The mechanism whereby alcohol reduces bone density is unknown but appears to be related to decreased bone formation. Abnormalities in vitamin D metabolism, parathyroid function, or gonadal function may also contribute to alcohol-related bone loss, although the evidence that any of these factors plays an important role is not convincing [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Calcium and vitamin D</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In observational studies, vitamin D deficiency is associated with osteoporosis, poor physical performance, and an increased risk of fractures [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/5,48,75\" class=\"abstract_t\">5,48,75</a>]. Evidence supporting the benefit of calcium and vitamin D supplementation in men with osteoporosis comes largely from prospective, randomized, placebo-controlled trials [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/76,77\" class=\"abstract_t\">76,77</a>]. Although a number of trials have reported a beneficial effect of calcium or calcium plus vitamin D on bone density in postmenopausal women and older men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/76-80\" class=\"abstract_t\">76-80</a>], the data on fracture rates are more variable [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/81\" class=\"abstract_t\">81</a>]. This topic is reviewed in detail separately. (See <a href=\"topic.htm?path=calcium-and-vitamin-d-supplementation-in-osteoporosis\" class=\"medical medical_review\">&quot;Calcium and vitamin D supplementation in osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Physical activity and strength</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Low levels of physical activity are associated with bone loss [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/2,52,82,83\" class=\"abstract_t\">2,52,82,83</a>] and a higher risk of fracture in older men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/84-87\" class=\"abstract_t\">84-87</a>]. As an example, in a cohort study of 2205 men aged 49 to 51 years, low or medium levels of physical activity were associated with more than a twofold higher risk of fracture, including hip fracture, compared with high physical activity (hazard ratio [HR] for hip fracture in low- or medium-activity compared with high-activity groups 2.31, 95% CI 1.39-3.85) [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/87\" class=\"abstract_t\">87</a>].</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Body weight</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Body weight is positively associated with bone density in older men, and weight loss appears to increase the rate of hip bone loss, even in obese men undergoing voluntary weight reduction [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/88\" class=\"abstract_t\">88</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Glucocorticoid excess</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both endogenous and exogenous glucocorticoid excess cause osteoporosis in men as well as in women. The osteoporosis is due primarily to the effects of glucocorticoid excess on bone, but glucocorticoid-induced hypogonadism may be a contributory factor. Glucocorticoid excess, which is nearly always caused by exogenous glucocorticoid therapy, is responsible for approximately 15 percent of vertebral fractures in men [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/4,89\" class=\"abstract_t\">4,89</a>], but some of the bone disease may be due to the underlying disorders for which glucocorticoids are given rather than the glucocorticoid therapy itself. (See <a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">&quot;Clinical features and evaluation of glucocorticoid-induced osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1089353736\"><span class=\"h2\">Growth hormone deficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In some studies, BMD of the lumbar spine (LS) is somewhat lower in untreated patients with adult-onset growth hormone deficiency compared with normal subjects. The degree of osteopenia appears to correlate directly with the degree of growth hormone deficiency. BMD often increases following growth hormone therapy. The skeletal effects of growth hormone deficiency are discussed in detail elsewhere. (See <a href=\"topic.htm?path=growth-hormone-deficiency-in-adults#H7\" class=\"medical medical_review\">&quot;Growth hormone deficiency in adults&quot;, section on 'Bone mineral density and fractures'</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Hypercalciuria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Men with hypercalciuria may have lower BMD than expected for age, particularly those in whom hypercalciuria persists despite a low calcium diet [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/90-95\" class=\"abstract_t\">90-95</a>].</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Idiopathic osteoporosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The 40 to 60 percent of men with osteoporosis in whom a cause cannot be identified are said to have idiopathic osteoporosis. Histomorphometric studies suggest that many have diminished bone formation [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/96-98\" class=\"abstract_t\">96-98</a>], but some have increased bone resorption [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/99\" class=\"abstract_t\">99</a>]. Many of these men probably have a genetic predisposition to osteoporosis [<a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/100\" class=\"abstract_t\">100</a>].</p><p>Serum insulin-like growth factor-1 (IGF-1) concentrations are low in some men with idiopathic osteoporosis (see <a href=\"topic.htm?path=normal-skeletal-development-and-regulation-of-bone-formation-and-resorption#H1206170\" class=\"medical medical_review\">&quot;Normal skeletal development and regulation of bone formation and resorption&quot;, section on 'Growth hormone and IGFs'</a>). Approximately 2 to 3 percent of men have a history of delayed puberty, which could be a precursor of idiopathic osteoporosis. Estrogen deficiency may also be responsible for otherwise unexplained osteoporosis in some men. (See <a href=\"#H6\" class=\"local\">'The role of hormones'</a> above.)</p><p class=\"headingAnchor\" id=\"H3090714654\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-osteoporosis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Osteoporosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In men, as in women, the incidence of fragility fractures increases exponentially with age, although the increase begins approximately 10 years later. However, the mortality rate associated with hip fractures, as well as vertebral and other major fractures, is higher in men than in women. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low bone mass in men may be due to suboptimal peak bone mass acquisition, ongoing bone loss, or reduced bone formation during remodeling. (See <a href=\"#H3\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In addition to low peak bone mass and age-related bone loss, a number of factors contribute to the development of osteoporosis and fracture in men, including smoking and chronic corticosteroid use. A history of prior fractures and history of falls within the past year are powerful predictors of future fractures.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A cause for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anticonvulsant drug therapy, hypercalciuria, and alcohol abuse are among the most common identifiable causes of osteoporosis in men (<a href=\"image.htm?imageKey=ENDO%2F60440\" class=\"graphic graphic_table graphicRef60440 \">table 1</a>). (See <a href=\"#H12\" class=\"local\">'Risk factors'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/1\" class=\"nounderline abstract_t\">Siddiqui NA, Shetty KR, Duthie EH Jr. Osteoporosis in older men: discovering when and how to treat it. Geriatrics 1999; 54:20.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/2\" class=\"nounderline abstract_t\">Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995; 16:87.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/3\" class=\"nounderline abstract_t\">Kelepouris N, Harper KD, Gannon F, et al. Severe osteoporosis in men. Ann Intern Med 1995; 123:452.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/4\" class=\"nounderline abstract_t\">Seeman E, Melton LJ 3rd, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75:977.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/5\" class=\"nounderline abstract_t\">Diamond T, Smerdely P, Kormas N, et al. Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism. Med J Aust 1998; 169:138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/6\" class=\"nounderline abstract_t\">Scane AC, Francis RM, Sutcliffe AM, et al. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 1999; 9:91.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/7\" class=\"nounderline abstract_t\">Farmer ME, White LR, Brody JA, Bailey KR. Race and sex differences in hip fracture incidence. Am J Public Health 1984; 74:1374.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/8\" class=\"nounderline abstract_t\">Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17:1726.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/9\" class=\"nounderline abstract_t\">Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996; 144:255.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/10\" class=\"nounderline abstract_t\">Melton LJ 3rd, Chrischilles EA, Cooper C, et al. Perspective. How many women have osteoporosis? J Bone Miner Res 1992; 7:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/11\" class=\"nounderline abstract_t\">Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip fracture in elderly men: prognostic factors and outcomes. Med J Aust 1997; 167:412.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/12\" class=\"nounderline abstract_t\">Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002; 162:2217.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/13\" class=\"nounderline abstract_t\">Kanis JA, Oden A, Johnell O, et al. The components of excess mortality after hip fracture. Bone 2003; 32:468.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/14\" class=\"nounderline abstract_t\">Trombetti A, Herrmann F, Hoffmeyer P, et al. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002; 13:731.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/15\" class=\"nounderline abstract_t\">Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353:878.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/16\" class=\"nounderline abstract_t\">Feldstein A, Elmer PJ, Orwoll E, et al. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163:2165.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/17\" class=\"nounderline abstract_t\">Krabbe S, Christiansen C. Longitudinal study of calcium metabolism in male puberty. I. Bone mineral content, and serum levels of alkaline phosphatase, phosphate and calcium. Acta Paediatr Scand 1984; 73:745.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/18\" class=\"nounderline abstract_t\">Krabbe S, Hummer L, Christiansen C. Longitudinal study of calcium metabolism in male puberty. II. Relationship between mineralization and serum testosterone. Acta Paediatr Scand 1984; 73:750.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/19\" class=\"nounderline abstract_t\">Gilsanz V, Gibbens DT, Roe TF, et al. Vertebral bone density in children: effect of puberty. Radiology 1988; 166:847.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/20\" class=\"nounderline abstract_t\">Bonjour JP, Theintz G, Buchs B, et al. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73:555.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/21\" class=\"nounderline abstract_t\">Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75:1060.</a></li><li class=\"breakAll\">Mazess RB, Cameron JR. Bone mineral content in normal U.S. whites. In: Proceedings, International Conference on Bone Mineral Measurement. Mazess, RB (Ed). DHEW Publication NIH 75-683, Washington, D.C. 1974; 228.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/23\" class=\"nounderline abstract_t\">Finkelstein JS, Klibanski A, Neer RM, et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987; 106:354.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/24\" class=\"nounderline abstract_t\">Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 1997; 82:658.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/25\" class=\"nounderline abstract_t\">Finkelstein JS, Neer RM, Biller BM, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992; 326:600.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/26\" class=\"nounderline abstract_t\">Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab 1996; 81:1152.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/27\" class=\"nounderline abstract_t\">Bertelloni S, Baroncelli GI, Battini R, et al. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995; 10:1488.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/28\" class=\"nounderline abstract_t\">Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008; 23:205.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/29\" class=\"nounderline abstract_t\">Nordstr&ouml;m P, Neovius M, Nordstr&ouml;m A. Early and rapid bone mineral density loss of the proximal femur in men. J Clin Endocrinol Metab 2007; 92:1902.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/30\" class=\"nounderline abstract_t\">Berger C, Langsetmo L, Joseph L, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008; 178:1660.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/31\" class=\"nounderline abstract_t\">Jones G, Nguyen T, Sambrook P, et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309:691.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/32\" class=\"nounderline abstract_t\">Orwoll ES, Oviatt SK, McClung MR, et al. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990; 112:29.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/33\" class=\"nounderline abstract_t\">Meier DE, Orwoll ES, Jones JM. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med 1984; 101:605.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/34\" class=\"nounderline abstract_t\">Zmuda JM, Cauley JA, Glynn NW, Finkelstein JS. Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res 2000; 15:1417.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/35\" class=\"nounderline abstract_t\">Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990; 70:1202.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/36\" class=\"nounderline abstract_t\">Fink HA, Ewing SK, Ensrud KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006; 91:3908.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/37\" class=\"nounderline abstract_t\">Mellstr&ouml;m D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006; 21:529.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/38\" class=\"nounderline abstract_t\">Ensrud KE, Lewis CE, Lambert LC, et al. Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int 2006; 17:1329.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/39\" class=\"nounderline abstract_t\">Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001; 86:3555.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/40\" class=\"nounderline abstract_t\">Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 2006; 119:426.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/41\" class=\"nounderline abstract_t\">Falahati-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000; 106:1553.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/42\" class=\"nounderline abstract_t\">Leder BZ, LeBlanc KM, Schoenfeld DA, et al. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 2003; 88:204.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/43\" class=\"nounderline abstract_t\">Finkelstein JS, Lee H, Leder BZ, et al. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest 2016; 126:1114.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/44\" class=\"nounderline abstract_t\">Bertelloni S, Baroncelli GI, Federico G, et al. Altered bone mineral density in patients with complete androgen insensitivity syndrome. Horm Res 1998; 50:309.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/45\" class=\"nounderline abstract_t\">Marcus R, Leary D, Schneider DL, et al. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2000; 85:1032.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/46\" class=\"nounderline abstract_t\">Sobel V, Schwartz B, Zhu YS, et al. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. J Clin Endocrinol Metab 2006; 91:3017.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/47\" class=\"nounderline abstract_t\">Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999; 84:3626.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/48\" class=\"nounderline abstract_t\">Orwoll ES, Meier DE. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab 1986; 63:1262.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/49\" class=\"nounderline abstract_t\">Rapado A, Hawkins F, Sobrinho L, et al. Bone mineral density and androgen levels in elderly males. Calcif Tissue Int 1999; 65:417.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/50\" class=\"nounderline abstract_t\">Leder BZ, Smith MR, Fallon MA, et al. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab 2001; 86:511.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/51\" class=\"nounderline abstract_t\">Drake MT, Murad MH, Mauck KF, et al. Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97:1861.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/52\" class=\"nounderline abstract_t\">Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore) 1990; 69:137.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/53\" class=\"nounderline abstract_t\">Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39:766.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/54\" class=\"nounderline abstract_t\">Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304:4.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/55\" class=\"nounderline abstract_t\">Stoch SA, Parker RA, Chen L, et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001; 86:2787.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/56\" class=\"nounderline abstract_t\">Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989; 110:430.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/57\" class=\"nounderline abstract_t\">Katznelson L, Finkelstein JS, Schoenfeld DA, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81:4358.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/58\" class=\"nounderline abstract_t\">Behre HM, Kliesch S, Leifke E, et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82:2386.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/59\" class=\"nounderline abstract_t\">Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69:776.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/60\" class=\"nounderline abstract_t\">Matzkin H, Chen J, Weisman Y, et al. Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf) 1992; 37:432.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/61\" class=\"nounderline abstract_t\">Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 1991; 6:39.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/62\" class=\"nounderline abstract_t\">Andersen AE, Watson T, Schlechte J. Osteoporosis and osteopenia in men with eating disorders. Lancet 2000; 355:1967.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/63\" class=\"nounderline abstract_t\">St&#277;p&aacute;n JJ, Lachman M, Zv&#277;rina J, et al. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69:523.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/64\" class=\"nounderline abstract_t\">Chen Z, Maricic M, Nguyen P, et al. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma. Cancer 2002; 95:2136.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/65\" class=\"nounderline abstract_t\">Smith MR, McGovern FJ, Zietman AL, et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 2001; 345:948.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/66\" class=\"nounderline abstract_t\">Maillefert JF, Sibilia J, Michel F, et al. Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma. J Urol 1999; 161:1219.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/67\" class=\"nounderline abstract_t\">Mittan D, Lee S, Miller E, et al. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 2002; 87:3656.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/68\" class=\"nounderline abstract_t\">Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol 1997; 157:439.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/69\" class=\"nounderline abstract_t\">Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352:154.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/70\" class=\"nounderline abstract_t\">Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 2002; 167:1952.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/71\" class=\"nounderline abstract_t\">Jutberger H, Lorentzon M, Barrett-Connor E, et al. Smoking predicts incident fractures in elderly men: Mr OS Sweden. J Bone Miner Res 2010; 25:1010.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/72\" class=\"nounderline abstract_t\">Slemenda CW, Christian JC, Reed T, et al. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117:286.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/73\" class=\"nounderline abstract_t\">Dal&eacute;n N, Lamke B. Bone mineral losses in alcoholics. Acta Orthop Scand 1976; 47:469.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/74\" class=\"nounderline abstract_t\">Spencer H, Rubio N, Rubio E, et al. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med 1986; 80:393.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/75\" class=\"nounderline abstract_t\">Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 92:2058.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/76\" class=\"nounderline abstract_t\">Daly RM, Brown M, Bass S, et al. Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial. J Bone Miner Res 2006; 21:397.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/77\" class=\"nounderline abstract_t\">Meier C, Woitge HW, Witte K, et al. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004; 19:1221.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/78\" class=\"nounderline abstract_t\">Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/79\" class=\"nounderline abstract_t\">Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008; 168:2276.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/80\" class=\"nounderline abstract_t\">Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000; 85:3011.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/81\" class=\"nounderline abstract_t\">Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 2008; 88:513S.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/82\" class=\"nounderline abstract_t\">Snow-Harter C, Whalen R, Myburgh K, et al. Bone mineral density, muscle strength, and recreational exercise in men. J Bone Miner Res 1992; 7:1291.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/83\" class=\"nounderline abstract_t\">Greendale GA, Barrett-Connor E, Edelstein S, et al. Lifetime leisure exercise and osteoporosis. The Rancho Bernardo study. Am J Epidemiol 1995; 141:951.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/84\" class=\"nounderline abstract_t\">Kujala UM, Kaprio J, Kannus P, et al. Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 2000; 160:705.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/85\" class=\"nounderline abstract_t\">Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2:16.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/86\" class=\"nounderline abstract_t\">Joakimsen RM, F&oslash;nneb&oslash; V, Magnus JH, et al. The Troms&oslash; Study: physical activity and the incidence of fractures in a middle-aged population. J Bone Miner Res 1998; 13:1149.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/87\" class=\"nounderline abstract_t\">Micha&euml;lsson K, Olofsson H, Jensevik K, et al. Leisure physical activity and the risk of fracture in men. PLoS Med 2007; 4:e199.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/88\" class=\"nounderline abstract_t\">Ensrud KE, Fullman RL, Barrett-Connor E, et al. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab 2005; 90:1998.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/89\" class=\"nounderline abstract_t\">Francis RM, Peacock M, Marshall DH, et al. Spinal osteoporosis in men. Bone Miner 1989; 5:347.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/90\" class=\"nounderline abstract_t\">Pacifici R, Rothstein M, Rifas L, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71:138.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/91\" class=\"nounderline abstract_t\">Weisinger JR, Alonzo E, Bellor&iacute;n-Font E, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996; 49:244.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/92\" class=\"nounderline abstract_t\">Ghazali A, Fuent&egrave;s V, Desaint C, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82:32.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/93\" class=\"nounderline abstract_t\">Bataille P, Achard JM, Fournier A, et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991; 39:1193.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/94\" class=\"nounderline abstract_t\">Borghi L, Meschi T, Guerra A, et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146:1334.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/95\" class=\"nounderline abstract_t\">Vezzoli G, Soldati L, Arcidiacono T, et al. Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 2005; 67:2006.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/96\" class=\"nounderline abstract_t\">Kurland ES, Rosen CJ, Cosman F, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1997; 82:2799.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/97\" class=\"nounderline abstract_t\">Hills E, Dunstan CR, Wong SY, Evans RA. Bone histology in young adult osteoporosis. J Clin Pathol 1989; 42:391.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/98\" class=\"nounderline abstract_t\">de Vernejoul MC, Bielakoff J, Herve M, et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res 1983; :107.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/99\" class=\"nounderline abstract_t\">Nordin BE, Aaron J, Speed R, et al. Bone formation and resorption as the determinants of trabecular bone volume in normal and osteoporotic men. Scott Med J 1984; 29:171.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-and-etiology-of-osteoporosis-in-men/abstract/100\" class=\"nounderline abstract_t\">Van Pottelbergh I, Goemaere S, Zmierczak H, et al. Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study. J Bone Miner Res 2003; 18:303.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2049 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H23\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOGENESIS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Peak bone mass</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Age-related bone loss</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">The role of hormones</a><ul><li><a href=\"#H2236970300\" id=\"outline-link-H2236970300\">- Testosterone</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Estrogen</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Estrogen versus testosterone</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Complete androgen insensitivity</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Other hormones</a></li></ul></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">RISK FACTORS</a><ul><li><a href=\"#H1525134674\" id=\"outline-link-H1525134674\">Hypogonadism</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Lifestyle factors</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">- Smoking and alcohol</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">- Calcium and vitamin D</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">- Physical activity and strength</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Body weight</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">Glucocorticoid excess</a></li><li><a href=\"#H1089353736\" id=\"outline-link-H1089353736\">Growth hormone deficiency</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Hypercalciuria</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Idiopathic osteoporosis</a></li></ul></li><li><a href=\"#H3090714654\" id=\"outline-link-H3090714654\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ENDO/2049|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/58577\" class=\"graphic graphic_figure\">- Average annual fracture rate</a></li><li><a href=\"image.htm?imageKey=ENDO/69980\" class=\"graphic graphic_figure\">- Radial bone density IHH</a></li><li><a href=\"image.htm?imageKey=ENDO/71184\" class=\"graphic graphic_figure\">- Spinal BMD with IHH</a></li><li><a href=\"image.htm?imageKey=ENDO/53843\" class=\"graphic graphic_figure\">- Percent change BMD older men</a></li><li><a href=\"image.htm?imageKey=ENDO/68642\" class=\"graphic graphic_figure\">- Op hip and gonadal steroids</a></li><li><a href=\"image.htm?imageKey=ENDO/64482\" class=\"graphic graphic_figure\">- Trabecular BMD hypogonadism</a></li></ul></li><li><div id=\"ENDO/2049|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ENDO/60440\" class=\"graphic graphic_table\">- Causes of osteoporosis men</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=bone-disease-in-diabetes-mellitus\" class=\"medical medical_review\">Bone disease in diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bone-disease-with-hyperthyroidism-and-thyroid-hormone-therapy\" class=\"medical medical_review\">Bone disease with hyperthyroidism and thyroid hormone therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calcium-and-vitamin-d-supplementation-in-osteoporosis\" class=\"medical medical_review\">Calcium and vitamin D supplementation in osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-primary-hypogonadism-in-males\" class=\"medical medical_review\">Causes of primary hypogonadism in males</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-secondary-hypogonadism-in-males\" class=\"medical medical_review\">Causes of secondary hypogonadism in males</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis\" class=\"medical medical_review\">Clinical features and evaluation of glucocorticoid-induced osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-hereditary-hemochromatosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of hereditary hemochromatosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-men\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and evaluation of osteoporosis in men</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-delayed-puberty\" class=\"medical medical_review\">Diagnosis and treatment of delayed puberty</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-disorders-of-the-androgen-receptor\" class=\"medical medical_review\">Diagnosis and treatment of disorders of the androgen receptor</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drugs-that-affect-bone-metabolism\" class=\"medical medical_review\">Drugs that affect bone metabolism</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=growth-hormone-deficiency-in-adults\" class=\"medical medical_review\">Growth hormone deficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=isolated-gonadotropin-releasing-hormone-deficiency-idiopathic-hypogonadotropic-hypogonadism\" class=\"medical medical_review\">Isolated gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=metabolic-bone-disease-in-inflammatory-bowel-disease\" class=\"medical medical_review\">Metabolic bone disease in inflammatory bowel disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=normal-skeletal-development-and-regulation-of-bone-formation-and-resorption\" class=\"medical medical_review\">Normal skeletal development and regulation of bone formation and resorption</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment\" class=\"medical medical_review\">Osteoporotic fracture risk assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">Overview of dual-energy x-ray absorptiometry</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">Overview of the management of osteoporosis in postmenopausal women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-and-clinical-manifestations-of-disorders-of-androgen-action\" class=\"medical medical_review\">Pathogenesis and clinical manifestations of disorders of androgen action</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-of-osteoporosis\" class=\"medical medical_review\">Pathogenesis of osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=side-effects-of-androgen-deprivation-therapy\" class=\"medical medical_review\">Side effects of androgen deprivation therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-osteoporosis\" class=\"medical medical_society_guidelines\">Society guideline links: Osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-osteoporosis-in-men\" class=\"medical medical_review\">Treatment of osteoporosis in men</a></li></ul></div></div>","javascript":null}